Comparative characteristics of the effectiveness of preventing the progression of CRF using therapy with secretome of embryonic cells and transplantation of neonatal tissues
Introduction. Literature data and our own research indicate that therapy with immature cell secretion products (secretome) has a pronounced nephroprotective effect both in acute kidney injury and in chronic renal failure (CRF).